Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Phase I/II Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Sponsor: Louisiana State University Health Sciences Center Shreveport
Terminated
Phase II not initiated due to cancellation of supply of Poly E by collaborator.
Other terminated trials from Louisiana State University Health Sciences Center Shreveport
- Myositis · Phase NA · Aug 2023
- Fractures, Comminuted · Phase PHASE2/PHASE3 · Mar 2015
- Head and Neck Squamous Cell Cancer · Phase PHASE2 · Feb 2014
- Metabolic Bone Disease · Sep 2011
- Mild Cognitive Impairment · Phase NA · Jun 2008
See all terminations from Louisiana State University Health Sciences Center Shreveport
Other Non-Small Cell Lung Cancer trials with similar outcome
Listed as NCT00707252, this PHASE1 trial focuses on Non-Small Cell Lung Cancer and remains terminated or withdrawn. Sponsored by Louisiana State University Health Sciences Center Shreveport, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Louisiana State University Health Sciences Center Shreveport
- Polyphenon E International,Inc.
For direct contact, visit the study record on ClinicalTrials.gov .